Open AccessProlonged exposure of colon cancer cells to the epidermal growth factor receptor inhibitor gefitinib (Iressa™) and to the antiangiogenic agent ZD6474: Cytotoxic and biomolecular effects
Author(s) -
Amalia Azzariti,
Letizia Porcelli,
Jianming Xu,
G. Simone,
Angelo Paradiso
Publication year - 2006
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.12.5140
Subject(s) - gefitinib , epidermal growth factor receptor , cancer research , cytotoxic t cell , colorectal cancer , epidermal growth factor , egfr inhibitors , medicine , cancer , oncology , pharmacology , chemistry , receptor , in vitro , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom